BiomedicinesNeurosciencePeer-reviewed journal article
DNA damage and senescence in the aging and Alzheimer's disease cortex are not uniformly distributed
Gnanesh GuttaiD, Jay MehtaiD, Rody KingstoniD, Jiaan XieiD, Eliana BrenneriD, Fulin MaiD, Karl HerrupiD
Abstract
Alzheimers disease (AD) is a neurodegenerative illness with a typical age of onset exceeding 65 years of age. The age-dependency of the condition led us to track the appearance of DNA damage in the frontal cortex of individuals who died with a diagnosis of AD. The focus on DNA damage was motivated by evidence that increasing levels of irreparable DNA damage are a major driver of the aging process. The connection between aging and the loss of genomic integrity is compelling because DNA damage has also been identified as a possible cause of cellular senescence. The number of senescent cells has been reported to increase with age, and their senescence-associated secreted products are likely contributing factors to age-related illnesses. We tracked DNA damage with 53BP1 and cellular senescence with p16 immunostaining of human post-mortem brain samples. We found that DNA damage is significantly increased in the BA9 region of the AD cortex when compared to the same region of unaXected controls (UC). In the AD but not UC cases, the density of cells with DNA damage increased with distance from the pia mater up to approximately layer V then decreased in deeper areas. This pattern of DNA damage was overlaid with the pattern of cellular senescence, which also increased with cortical depth. On a cell-by-cell basis, we found that the intensity of the two markers was tightly linked in the AD, but not the UC brain. To test whether DNA damage was a causal factor in the emergence of the senescence program, we used etoposide treatment to damage the DNA of cultured mouse primary neurons. While DNA damage increased after treatment, after 24 hours no change in the expression of senescence-associated markers was observed. Our work suggests that DNA damage and cellular senescence are both increased in the AD brain and increasingly coupled. We propose that in vivo the relationship between the two age-related processes is more complex than previously thought.
- organism: human
- organism: mouse
- assay: imaging
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 6
- FWCI
- 1.71
- Field percentile
- top 17%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DNA damage drives a unique, Alzheimer's disease-relevant senescent state in neurons
Jun‐Wei B. Hughes, Anja Sandholm, … Judith Campisi·bioRxiv·Apr 3, 2026
- The interaction between aging and DNA damage influences the accumulation of APP in Alzheimer's disease
Eliana Brenner, Gnanesh Gutta, … Fulin Ma·bioRxiv·Sep 7, 2025
- Telomere-induced senescence increases aberrant intraneuronal amyloid-β accumulation by impairing autophagy in a mouse model of Alzheimer's disease
Núria Suelves, Shirine Saleki, … Pascal Kienlen‐Campard·Acta Neuropathologica CommunicationsPeer-reviewed·May 17, 2023
- From aging to Alzheimer's disease: concordant brain DNA methylation changes in late life
David Lukacsovich, Juan I. Young, … Alzheimer’s Disease Neuroimaging Initiative·Genome MedicinePeer-reviewed·Jun 16, 2026
- Associations between regional blood-brain barrier disruption, aging, and Alzheimers disease biomarkers in cognitively normal older adults
Marisa N. Denkinger, Suzanne L. Baker, … William J. Jagust·PLoS ONEPeer-reviewed·Jun 5, 2024
- Cellular dynamics across aged human brains uncover a multicellular cascade leading to Alzheimer's disease
Gilad Sahar Green, Masashi Fujita, … Philip L. De Jager·Alzheimer s & DementiaPeer-reviewed·Dec 1, 2023